ICTI Expands European Operations
January 10, 2006
Interactive Clinical Technologies, Inc. (ICTI) will expand European Operations with the addition of a new 10,000 square foot facility on the Almac Sciences corporate campus in Craigavon, United Kingdom.
The new Craigavon facility will allow ICTI to respond to increased demand for its phone and web based clinical trial technologies and services by increasing staff levels and adding information technology positions to its European operations.
ICTI management attributes the increased demand to three key factors. First, ICTI has gained a number of new European pharmaceutical and biotechnology customers during the past 12 months. Second, several existing customers have begun to purchase multiple components from ICTI’s integrated technology and service suite. Thirdly, an increasing number of ICTI’s clients are taking advantage of EZ-Link, the complete drug supply management solution from ICTI and sister company CTS.
Richard McCann, President of ICTI said about the expansion,
“ICTI has been very successful in establishing and maintaining strong relationships with many of the top European pharmaceutical and biotechnology companies. With this success has come the need to grow. By expanding our European presence with a new office on the Almac campus, ICTI will increase capacity and further leverage strategic service synergies with Clinical Trial Services (CTS) as well as other Almac Sciences companies.”
About ICTI and Almac Sciences
ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trial process and reduce the costs of clinical trials. Our solutions include IVRS and web based patient randomization, dosing and clinical supply management; iTrial EDC for electronic case report form data collection; iDiary phone-based patient diaries; and iForecasting for clinical trial materials planning.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and ArraDx (Array Based Diagnostics)) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.
For further information, please contact:
Jim Murphy or Meghan Adams